Acumen Pharmaceuticals, Inc. - 8-K Filing
Acumen Pharmaceuticals terminates $50M loan facility with K2 HealthVentures and initiates restructuring involving 90% workforce reduction. (Items: 1.02 Termination of a Material Definitive Agreement, 2.05 Costs Associated with Exit or Disposal Activities, 9.01 Financial Statements and Exhibits)
Tickers: $ABOS